We regulate medicines, medical devices and cosmetics, to promote human and animal health.
Kindly be reminded that as previously advised in the stakeholder engagement and BoMRA communication of Ref: MRA 6/2/4 Vol. 1(98) , BoMRA has commenced licensing of schedule 4 and complementary medicines importers since January 2023.
The Medical Devices Unit of the Botswana Medicines Regulatory Authority (BoMRA) would like to inform its valued stakeholders that the listing database of medical devices including In-Vitro Diagnostics (IVDs) devices has been published on the BoMRA website.
Reference is made to the above subject matter and the call for payment of annual
In accordance with clause 8.5 of the Contract Management procedure, the Procurement Unit must publish
The Medicines Regulatory Board (“board”) Botswana Medicines Regulation Authority (“BoMRA”) would like to announce the
The Department of Product Evaluation & Registration at BoMRA will conduct virtualstakeholder sessions to discuss
The Botswana Medicines Regulatory Authority (BoMRA) Was established through the Medicines and Related Substances Act of 2013. The MRSA Authorises BoMRA to perform functions given by the shareholder – The Government of Botswana. The MRSA of 2013 replaced the repealed Drugs and Related Substances Act No.
Designed And Developed By Ntebogang Technologies
COVID-19 Updates
 Covid19 Updates